We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
-12.61%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$44.7B
AUM Growth
-$8.1B
Cap. Flow
-$586M
Cap. Flow %
-1.31%
Top 10 Hldgs %
11.88%
Holding
3,156
New
191
Increased
1,075
Reduced
1,341
Closed
252

Sector Composition

Rank Sector Weight
1 Financials 17.48%
2 Technology 14.18%
3 Healthcare 12.93%
4 Consumer Discretionary 9.58%
5 Industrials 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SURF
2776
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$15K ﹤0.01%
+3,500
New +$27K
OMN
2777
DELISTED
OMNOVA Solutions Inc.
OMN
$15K ﹤0.01%
+2,037
New +$16.4K
NBLX
2778
DELISTED
Noble Midstream Partners LP
NBLX
$14K ﹤0.01%
500
TTPH
2779
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$14K ﹤0.01%
590
APVO icon
2780
Aptevo Therapeutics
APVO
$5.06M
0
OKTA icon
2781
Okta
OKTA
$26.4B
$13K ﹤0.01%
+202
New +$12K
ARAV
2782
DELISTED
Aravive, Inc. Common Stock
ARAV
$13K ﹤0.01%
3,696
FPRX
2783
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$13K ﹤0.01%
1,400
-4,800
-77% -$57.1K
MCB icon
2784
Metropolitan Bank Holding Corp
MCB
$1.14B
$12K ﹤0.01%
400
-2,990
-88% -$110K
MTL
2785
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$12K ﹤0.01%
5,900
IRCP
2786
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
$10K ﹤0.01%
+2,294
New +$11.7K
GEN
2787
DELISTED
Genesis Healthcare, Inc.
GEN
$10K ﹤0.01%
+8,514
New +$12.6K
CECO icon
2788
Ceco Environmental
CECO
$4.02B
$9K ﹤0.01%
1,300
MBIN icon
2789
Merchants Bancorp
MBIN
$2.46B
$9K ﹤0.01%
693
-4,784
-87% -$71.9K
SNDX icon
2790
Syndax Pharmaceuticals
SNDX
$1.83B
$9K ﹤0.01%
2,000
-1,900
-49% -$10.4K
TSRO
2791
DELISTED
TESARO, Inc.
TSRO
$9K ﹤0.01%
124
BOCH
2792
DELISTED
Bank of Commerce Holdings (CA)
BOCH
$7K ﹤0.01%
+571
New +$6.64K
OTIC
2793
DELISTED
Otonomy, Inc.
OTIC
$6K ﹤0.01%
3,300
-1,700
-34% -$4.01K
AGIO icon
2794
Agios Pharmaceuticals
AGIO
$1.93B
$5K ﹤0.01%
114
-163
-59% -$10.1K
IR icon
2795
Ingersoll Rand
IR
$33.7B
$5K ﹤0.01%
253
AKRX
2796
DELISTED
Akorn Inc
AKRX
$5K ﹤0.01%
1,383
ASPN icon
2797
Aspen Aerogels
ASPN
$529M
$4K ﹤0.01%
2,000
FTR
2798
DELISTED
Frontier Communications Corp.
FTR
$3K ﹤0.01%
1,404
OVID icon
2799
Ovid Therapeutics
OVID
$476M
$1K ﹤0.01%
+500
New +$2.28K
ACMR icon
2800
ACM Research
ACMR
$5.69B
-222,204
Closed -$819K

Similar funds

Russell Investments Group's Q4 2018 Portfolio in Review

As of Q4 2018, Russell Investments Group held 3,156 positions worth $44.7B, down 15% from $52.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Russell Investments Group's Q4 2018 filing shows 191 new, 1,075 increased, 1,341 reduced and 252 closed positions. Its largest new stake was Linde: 667,118 shares worth $104M. The largest sale was Vanguard Real Estate ETF, an estimated $189M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • Russell Investments Group's largest Q4 2018 buy was Linde: 667,118 shares worth $104M.
  • Russell Investments Group added most to Vistance Networks Inc in Q4 2018, an estimated $100M increase.
  • Russell Investments Group's biggest Q4 2018 reduction was Apple, cutting an estimated $87.6M.
  • Russell Investments Group fully exited Vanguard Real Estate ETF in Q4 2018, selling an estimated $189M.
  • Russell Investments Group's ten largest holdings make up 12% of its $44.7B portfolio in Q4 2018.
  • Russell Investments Group opened 191 new positions and closed 252 in Q4 2018.
  • Russell Investments Group's portfolio value fell 15% quarter-over-quarter to $44.7B.

Based on Russell Investments Group's 13F filing for Q4 2018, filed 11 Feb 2019.